Ulla Stromberg-Olsson
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancer.
Journal: Immuno-oncology technology
Published: March 11, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.
Journal: Leukemia
Published: November 28, 2025
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase.
Journal: Leukemia
Published: October 30, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML.
Journal: Leukemia
Published: May 21, 2025
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.
Journal: Leukemia
Published: April 23, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 12, 2024
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Journal: Leukemia
Published: November 01, 2023
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.
Journal: Leukemia
Published: September 14, 2023
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.
Journal: Leukemia
Published: March 31, 2023
Last Updated: 09/26/2026